Topically Applied Imiquimod Inhibits Vascular Tumor Growth In Vivo
- 1 November 2003
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 121 (5) , 1205-1209
- https://doi.org/10.1046/j.1523-1747.2003.12521.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- TIMP-1 Overexpression in Pancreatic Cancer Attenuates Tumor Growth, Decreases Implantation and Metastasis, and Inhibits AngiogenesisJournal of Surgical Research, 2002
- Clonality and altered behavior of endothelial cells from hemangiomasJournal of Clinical Investigation, 2001
- Imiquimod in clinical practiceJournal of the American Academy of Dermatology, 2000
- Steroid Therapy of a Proliferating Hemangioma: Histochemical and Molecular ChangesPediatrics, 2000
- Hemangiomas in ChildrenNew England Journal of Medicine, 1999
- Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancyThe Journal of Pediatrics, 1998
- Infants with Kasabach-Merritt syndrome do not have “true” hemangiomasThe Journal of Pediatrics, 1997
- Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of InfancyNew England Journal of Medicine, 1992
- Multiple Topical Applications of Arachidonic Acid to Mouse Ears Induce Inflammatory and Proliferative ChangesJournal of Investigative Dermatology, 1988
- Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substratesAnalytical Biochemistry, 1980